2024/03/30 更新

写真a

カキノキ サチロウ
柿木 佐知朗
KAKINOKI,Sachiro
所属
化学生命工学部 教授
職名
教授
外部リンク

学位

  • 博士(工学) ( 2005年3月 )

研究キーワード

  • ペプチド

  • タンパク質工学

  • ペプチド;タンパク質工学;

  • バイオマテリアル

  • 組織工学

  • バイオマテリアル;組織工学;

研究分野

  • ナノテク・材料 / 基礎物理化学

  • ナノテク・材料 / 生体化学

  • ナノテク・材料 / 生物分子化学

  • ライフサイエンス / 生体医工学

  • ライフサイエンス / 生体材料学

学歴

  • 大阪府立大学   工学研究科   物質系専攻

    2005年

      詳細を見る

  • 近畿大学   総合理工学研究科   物質系工学専攻

    2002年

      詳細を見る

  • 近畿大学   理工学部   原子炉工学科

    - 2000年

      詳細を見る

  • 大阪府立大学   工学研究科   物質系専攻

    2005年

      詳細を見る

経歴

  • 関西大学   化学生命工学部 化学・物質工学科   教授   博士(工学)

    2022年4月 - 現在

      詳細を見る

    国名:日本国

    researchmap

  • 関西大学   化学生命工学部 化学・物質工学科   准教授   博士(工学)

    2015年4月 - 2022年3月

      詳細を見る

    国名:日本国

    researchmap

  • (独)国立循環器病研究センター研究所 生体医工学部 研究員(常勤)

    2010年4月 - 2015年3月

      詳細を見る

  • 国立循環器病センター研究所 生体工学部 流動研究員

    2007年4月 - 2010年3月

      詳細を見る

  • (独)物質・材料研究機構生体材料センター高次機能生体材料グループ NIMSポスドク研究員

    2006年4月 - 2007年3月

      詳細を見る

  • (独)物質・材料研究機構生体材料研究センター人工臓器材料グループ 特別研究員

    2005年4月 - 2006年3月

      詳細を見る

▼全件表示

所属学協会

▼全件表示

委員歴

  • Journal of Artificial Organs   Editorial Board  

    2022年4月 - 現在   

      詳細を見る

    団体区分:その他

    researchmap

  • Journal of Materials Science: Materials in Medicine   Board of Assistant Editors  

    2021年7月 - 現在   

      詳細を見る

    団体区分:その他

    researchmap

  • 日本人工臓器学会   評議員  

    2017年5月 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

  • 日本バイオマテリアル学会   評議員  

    2012年4月 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

論文

  • Microwave-Assisted Incorporation of AgNP into Chitosan–Alginate Hydrogels for Antimicrobial Applications

    Takuma Oe, Duangkamol Dechojarassri, Sachiro Kakinoki, Hideya Kawasaki, Tetsuya Furuike, Hiroshi Tamura

    Journal of Functional Biomaterials   2023年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.3390/jfb14040199

    researchmap

  • 末梢神経再生治療の最前線-基礎から臨床へ- 末梢神経再生デバイスの新たなデザインとその評価法

    山岡 哲二, 小川 興, 徐 于懿, 柿木 佐知朗, 森本 尚樹

    日本整形外科学会雑誌   97 ( 2 )   S152 - S152   2023年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本整形外科学会  

    researchmap

  • Stable and direct coating of fibronectin-derived Leu-Asp-Val peptide on ePTFE using one-pot tyrosine oxidation for endothelial cell adhesion 査読

    Sachiro Kakinoki, Satoru Nishioka, Yuki Arichi, Tetsuji Yamaoka

    Colloids Surf. B   216, 112576   2022年8月

     詳細を見る

  • Dynamic in vitro hemocompatibility of oligoproline self-assembled monolayer surfaces 査読

    Aldona Mzyk, Gabriela Imbir, Yuri Noguchi, Marek Sanak, Roman Major, Justyna Wiecek, Przemyslaw Kurtyka, Hanna Plutecka, Klaudia Trembecka-Wójciga, Yasuhiko Iwasaki, Masato Ueda, Sachiro Kakinoki

    Biomaterials Science   10, 5498-5503   2022年7月

     詳細を見る

  • Long-lasting hydrophilic surface generated on poly(dimethyl siloxane) with photoreactive zwitterionic polymers. 国際誌

    Hiroki Nakano, Sachiro Kakinoki, Yasuhiko Iwasaki

    Colloids and surfaces. B, Biointerfaces   205   111900 - 111900   2021年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Poly(dimethylsiloxane) (PDMS) is known as one of the most established polymers for making elastomers. Therefore, it is commonly used for the fabrication of biomedical devices. Many PDMS surface modification processes have been proposed recently to increase PDMS reliability in medical fields. However, the modified surface's long-term stability is still limited. Hydrophobic recovery of PDMS is widely recognized as a factor that reduces the efficacy of PDMS surface modification. The photoreactive zwitterionic polymer effectively suppresses the hydrophobic recovery of PDMS, according to the current analysis. The photoreactive zwitterionic monomer, 2-[2-(Methacryloyloxy)ethyldimethylanmmonium] ethyl benzophenoxy phosphate (MBPP) was polymerized by conventional radical polymerization and coated on O2-plasma-treated PDMS specimens. The specimens were immersed in an aqueous solution of 2-methacryloyloxyethyl phosphorylcholine (MPC) and exposed under ultraviolet (UV) radiation for 3 h. Instead, of poly(MBPP) (PMBPP), benzophenone (BP) was also used as a conventional photoinitiator. The time-dependent change in the wettability and elemental composition of the specimen surface was monitored for nine weeks after photo-grafting of poly[2-methacryloyloxyethyl phosphorylcholine (MPC)] (PMPC). The advancing and receding contact angles (θA/θR) of the pristine PDMS specimen were 112°/71° and significantly decreased immediately after the grafting of PMPC regardless of types of photoinitiator. However, the hydrophobicity of the surface gradually recovered, and θA was changed from 12° to 81° for nine weeks of storage under air atmosphere when BP was used as a photoinitiator for graft polymerization of MPC. However, surface hydrophilicity (θA ≅ 20°) of the surface grafted with PMPC with PMBPP as an initiator was effectively preserved for nine weeks. This surface also showed excellent lubricity and non-fouling properties regardless of the storage periods. Therefore, zwitterionic photoreactive polymer, PMBPP, is then used as a macrophotoinitiator for the surface modification of PDMS.

    DOI: 10.1016/j.colsurfb.2021.111900

    PubMed

    researchmap

  • A well plate–based multiplexed platform for incorporation of organoids into an organ-on-a-chip system with a perfusable vasculature

    Benjamin Fook Lun Lai, Rick Xing Ze Lu, Locke Davenport Huyer, Sachiro Kakinoki, Joshua Yazbeck, Erika Yan Wang, Qinghua Wu, Boyang Zhang, Milica Radisic

    Nature Protocols   16 ( 4 )   2158 - 2189   2021年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Owing to their high spatiotemporal precision and adaptability to different host cells, organ-on-a-chip systems are showing great promise in drug discovery, developmental biology studies and disease modeling. However, many current micro-engineered biomimetic systems are limited in technological application because of culture media mixing that does not allow direct incorporation of techniques from stem cell biology, such as organoids. Here, we describe a detailed alternative method to cultivate millimeter-scale functional vascularized tissues on a biofabricated platform, termed ‘integrated vasculature for assessing dynamic events’, that enables facile incorporation of organoid technology. Utilizing the 3D stamping technique with a synthetic polymeric elastomer, a scaffold termed ‘AngioTube’ is generated with a central microchannel that has the mechanical stability to support a perfusable vascular system and the self-assembly of various parenchymal tissues. We demonstrate an increase in user familiarity and content analysis by situating the scaffold on a footprint of a 96-well plate. Uniquely, the platform can be used for facile connection of two or more tissue compartments in series through a common vasculature. Built-in micropores enable the studies of cell invasion involved in both angiogenesis and metastasis. We describe how this protocol can be applied to create both vascularized cardiac and hepatic tissues, metastatic breast cancer tissue and personalized pancreatic cancer tissue through incorporation of patient-derived organoids. Platform assembly to populating the scaffold with cells of interest into perfusable functional vascularized tissue will require 12–14 d and an additional 4 d if pre-polymer and master molds are needed.

    DOI: 10.1038/s41596-020-00490-1

    Scopus

    PubMed

    researchmap

  • Effect of Residue Insertion on the Stability of Polyproline-I and II Structures: Circular Dichroism Spectroscopic Analyses of Block-Type Oligo-Prolines (Pro)m-Gly/Ala-(Pro)n 査読

    KAKINOKI,Sachiro, KITAMURA, Makoto, NOGUCHI, Yuri, ARICHI, Yuki

    Pept. Sci.   e24170   2020年4月

     詳細を見る

  • Surfaces immobilized with oligo-prolines prevent protein adsorption and cell adhesion. 査読 国際誌

    Yuri Noguchi, Yasuhiko Iwasaki, Masato Ueda, Sachiro Kakinoki

    Journal of materials chemistry. B   8 ( 11 )   2233 - 2237   2020年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In this study, oligo-prolines, (Pro)n (n = 6 and 9) inspired by the backbone structure of collagen, were evaluated as a novel non-ionic anti-fouling peptide. Two oligo-prolines with a cysteine residue were synthesized and immobilized on gold substrates via Au-thiol binding. The surfaces immobilized with oligo-prolines, and forming a polyproline-II conformation, indicated hydrophilic properties (water contact angle ≈ 25 degrees). The degree of adsorption of human serum albumin, human fibrinogen, and bovine serum components on these surfaces was quantified using a quartz crystal. The immobilization of oligo-prolines prevented the adsorption of proteins and serum components including small molecules, such as fatty acids. Pro9 specifically indicated good resistance to the adsorption of all components due to the highly-packed Pro9 chains on the surface. The adhesion of fibroblasts was drastically suppressed on the surfaces immobilized with oligo-prolines. Our findings suggest that oligo-proline-immobilized surfaces, specifically Pro9-s, are useful for the development of novel vascular devices that have ultra-low fouling properties.

    DOI: 10.1039/d0tb00051e

    PubMed

    researchmap

  • Highly Durable Lubricity of Photo-Cross-Linked Zwitterionic Polymer Brushes Supported by Poly(ether ether ketone) Substrate 査読

    Hiroki Nakano, Yuri Noguchi, Sachiro Kakinoki, Mai Yamakawa, Issey Osaka, Yasuhiko Iwasaki

    ACS Applied Bio Materials   2020年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:American Chemical Society ({ACS})  

    DOI: 10.1021/acsabm.9b01040

    researchmap

  • Short‐term evaluation of thromboresistance of a poly(ether ether ketone) (PEEK) mechanical heart valve with poly(2‐methacryloyloxyethyl phosphorylcholine) (PMPC)‐grafted surface in a porcine aortic valve replacement model 査読 国際誌

    Yusuke Kambe, Atsushi Mahara, Hiroshi Tanaka, Sachiro Kakinoki, Kyoko Fukazzwa, Yihua Liu, Masayuki Kyomoto, Kenji Minatoya, Kazuhiko Ishihara, Tetsuji Yamaoka

    J. Biomed. Mat. Res. A   107 ( 5 )   1052 - 1063   2019年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1002/jbm.a.36628

    Scopus

    PubMed

    researchmap

  • Surface modification of porous alpha-tricalcium phosphate granules with heparin enhanced their early osteogenic capability in a rat calvarial defect model. 査読

    Yoshihiro Takeda, Yoshitomo Honda, Sachiro Kakinoki, Tetsuji Yamaoka, Shunsuke Baba

    Dental materials journal   37 ( 4 )   575 - 581   2018年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Heparin binds to and modulates various growth factors, potentially augmenting the bone-forming capability of biomaterials. Here, α-tricalcium phosphate (α-TCP) granules were modified with peptide containing the marine mussel-derived adhesive sequence, which reacts with α-TCP surface, and cationic sequence, which binds to heparin (α-Ph). α-Ph retained the α-TCP phase and intergranule spaces after the surface modification. The existence of heparin on α-Ph granules was confirmed using X-ray photoelectron spectroscopy. Granules of α-TCP and α-Ph were implanted into critical-size defects in rat calvaria for 4 weeks. Micro-computed tomography, histological evaluation, and Alcian blue staining revealed that α-Ph induced superior bone formation compared with α-TCP. Newly formed bone on α-Ph was preferentially in contact with the Alcian blue-stained surfaces of granules. These results suggested that heparinization enhanced the early osteogenic capacity of α-TCP, possibly by modulating the secretion of Alcian blue-stained extracellular matrixes.

    DOI: 10.4012/dmj.2017-305

    Scopus

    PubMed

    researchmap

  • Periodontal regeneration induced by porous alpha-tricalcium phosphate with immobilized basic fibroblast growth factor in a canine model of 2-wall periodontal defects. 査読

    Kazuya Matsuse, Yoshiya Hashimoto, Sachiro Kakinoki, Tetsuji Yamaoka, Shosuke Morita

    Medical molecular morphology   51 ( 1 )   48 - 56   2018年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We evaluated the effect of porous alpha-tricalcium phosphate (α-TCP) with immobilized basic fibroblast growth factor (bFGF) on periodontal regeneration in a canine model of 2-wall periodontal defects. Identical bone defects were made in the canine mandible; six defects in each animal were filled with porous α-TCP with bFGF bound via heparin (bFGF group), and the remaining defects were filled with unmodified porous α-TCP (control group). Micro-computed tomography and histological evaluation were performed at 2, 4, and 8 weeks post-implantation. The bone mineral content of the bFGF group was higher than that of the control group at 2 and 4 weeks (p < 0.05). Histological evaluation at 2 weeks post-implantation revealed degradation of the porous α-TCP, and bone had formed on the surface of α-TCP particles in the bFGF group. Some of these collagen fibers connected the newly formed cementum with the alveolar bone, revealing the formation of new periodontal ligaments with Sharpey's fibers. At 8 weeks, continuous cortical bone with a Haversian structure covered the top of the bone defects in the bFGF group. These findings indicate that porous α-TCP with immobilized bFGF could promote periodontal regeneration at the early regeneration phase in a canine model of 2-wall periodontal defects.

    DOI: 10.1007/s00795-017-0172-9

    PubMed

    researchmap

  • Direct surface modification of metallic biomaterials via tyrosine oxidation aiming to accelerate the re-endothelialization of vascular stents. 査読 国際誌

    Sachiro Kakinoki, Kensuke Takasaki, Atsushi Mahara, Tomo Ehashi, Yoshiaki Hirano, Tetsuji Yamaoka

    Journal of biomedical materials research. Part A   106 ( 2 )   491 - 499   2018年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Rapid in-situ re-endothelialization of coronary stents is one of the most effective approaches to inhibit late thrombosis and restenosis. Strut surfaces allowing excellent adhesion and migration of endothelial cells and endothelial progenitor cells may accelerate in-situ re-endothelialization. Here, a well-known endothelial cell adhesive peptide, Arg-Glu-Asp-Val (REDV), was directly immobilized onto metallic surfaces by means of single-step tyrosine oxidation with copper chloride (II) and hydrogen peroxide, which we recently reported as a new biomaterial modification technique. REDV immobilization on a 316L stainless steel plate improved endothelial cell adhesion and effectively suppressed platelet adhesion in vitro. In addition, a Co-Cr stent immobilized with Ac-Tyr-Gly-Gly-Gly-Arg-Glu-Asp-Val (Y-REDV) was implanted into a rabbit abdominal aorta. On 7 days postimplantation, 80% of the strut surface of the Y-REDV-immobilized stent was covered by a thin neointimal layer and was similar in appearance to native endothelium. Restenosis and late thrombosis were not observed in the Y-REDV-immobilized stent for 42 days. These findings suggest that direct immobilization of Y-REDV peptide onto metallic biomaterials by tyrosine oxidation is effective for promoting in-situ re-endothelialization in vascular stents. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 491-499, 2018.

    DOI: 10.1002/jbm.a.36258

    Scopus

    PubMed

    researchmap

  • Individual evaluation of cardiac marker expression and self-beating during cardiac differentiation of P19CL6 cells on different culture substrates. 査読 国際誌

    Tetsuji Yamaoka, Mitsuhi Hirata, Takaaki Dan, Atsushi Yamashita, Akihisa Otaka, Takahiko Nakaoki, Azizi Miskon, Sachiro Kakinoki, Atsushi Mahara

    Journal of biomedical materials research. Part A   105 ( 4 )   1166 - 1174   2017年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    Cell-based therapies using self-beating cardiomyocytes have been attracting great attention for use in cardiac regeneration, although an effective procedure to improve cardiac differentiation and self-beating induction is required. The purpose of this study is to clarify the effect of the culture substrate on cardiac maturation by separately evaluating the cardiac differentiation step and the beating induction step in vitro. To this end, the well-studied cardiomyocyte-like progenitor cell line P19CL6 and neonatal cardiomyocytes (NCMs) were selected and cultured on substrates coated with collagen type I (Col-I), gelatin (Gel), fibronectin (FN), or poly-l-lysine (PLL). It was found that the cardiac differentiation step, which was assessed using cardiac marker gene expression (GATA-binding protein 4 (GATA4), myocyte-specific enhancer factor 2D (MEF2D), and hyperpolarization-activated cyclic nucleotide-gated potassium channel 4 (HCN4)) in the P19CL6 embryonal carcinoma cells, was greatly enhanced on Col-I, Gel, and PLL. In contrast, the spontaneous beating step, which was directly assessed by counting the beating colonies and measuring contractile protein gene expression (α-myosin heavy chain (α-MHC), troponin C type 1 (TnC1), and troponin T type 2 (TnT2)) in the rat NCMs, was enhanced on the FN and PLL surfaces. In the present study, for the first time, it was found that PLL enhances both the cardiac differentiation and the beating induction steps of cardiac maturation, which can aid in preparing beating cardiomyocytes for regenerative medicine. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 1166-1174, 2017.

    DOI: 10.1002/jbm.a.35977

    Web of Science

    PubMed

    researchmap

  • Direct surface modification of metallic biomaterials via tyrosine oxidation aiming to accelerate the re-endothelialization of vascular stents 査読

    Sachiro Kakinoki, Kensuke Takasaki, Atsushi Mahara, Tomo Ehashi, Yoshiaki Hirano, Tetsuji Yamaoka

    J. Biomed. Mat. Res. A   In press   2017年

     詳細を見る

  • 機能性バイオインターフェイスの新潮流 細胞機能制御を指向した分子可動性ポリロタキサン表面の構築

    有坂 慶紀, 徐 知勲, 田村 篤志, 柿木 佐知朗, 山岡 哲二, 由井 伸彦

    日本バイオマテリアル学会大会予稿集   シンポジウム2016   183 - 183   2016年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本バイオマテリアル学会  

    researchmap

  • Dynamic polyrotaxane-coated surface for effective differentiation of mouse induced pluripotent stem cells into cardiomyocytes

    Ji-Hun Seo, Mitsuhi Hirata, Sachiro Kakinoki, Tetsuji Yamaoka, Nobuhiko Yui

    RSC ADVANCES   6 ( 42 )   35668 - 35676   2016年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROYAL SOC CHEMISTRY  

    The effect of increasing molecular mobility, on hydrated polyrotaxane (PRX)-coated surfaces, on differentiation of mouse induced pluripotent stem cells (iPS cells) into cardiomyocytes was examined. PRX is composed of a-cyclodextrin (alpha-CD) threaded on linear poly(ethylene glycol) (PEG)-capped terminals with bulky end-groups. The degree of molecular mobility at the hydrated state (Mf) on the PRX surfaces can be varied by changing the number of threaded alpha-CDs. Rac1 expression was significantly upregulated for adhering iPS cells on the PRX surface with high Mf value, while it was downregulated on surfaces with low Mf value. Furthermore, the expression of N-cadherin, which is an important marker protein for cardiomyogenic differentiation of stem cells, was greatly upregulated for adhering iPS cells on the PRX surface with high Mf value, while those on surfaces with low Mf value showed low Ncadherin expression. Finally, the PRX surface with higher Mf value was found to be higher in cardiomyogenesis and beating colony formation from iPS cells, the extent of which was much higher than that on gelatin-coated surfaces. This suggests that surface hydrated molecular mobility, varied by varying a supramolecular PRX architecture on materials, plays a significant role in controlling cytoskeletal signaling pathways, eventually contributing to the direction of stem cell commitment.

    DOI: 10.1039/c6ra03967g

    Web of Science

    researchmap

  • Accelerated tissue integration into porous materials by immobilizing basic fibroblast growth factor using a biologically safe three-step reaction. 査読 国際誌

    Sachiro Kakinoki, Yusuke Sakai, Toshia Fujisato, Tetsuji Yamaoka

    Journal of biomedical materials research. Part A   103 ( 12 )   3790 - 7   2015年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Soft tissue integration into a porous structure is important to prevent bacterial infection of percutaneous devices and improve tissue regeneration using porous scaffolds. Here, basic fibroblast growth factor (bFGF) was immobilized on porous polymer materials using a mild and biologically safe three-step reaction: (1) modification with a novel surface-modification peptide (penta-lysine-mussel adhesive sequence, which reacts with various matrices), (2) electrostatic binding of heparin with introduced penta-lysine, and (3) biologically specific binding of bFGF to heparin. Porous polyethylene specimens (PPSs) (D = 6.0 mm, H = 2.0 mm) with a good size for tissue integration were selected as a base material, immobilized with bFGF, and subcutaneously implanted into mice. Half of the unmodified PPSs extruded out of the body on day 112 postimplantation; however, the three-step reaction completely prevented sample rejection. Tissue integration was greatly accelerated by immobilizing bFGF. Direct physical coating of bFGF on PPS resulted in greater immobilization but lesser tissue integration than that after the three-step bFGF immobilization, indicating that heparin binds and enhances bFGF efficacy. This three-step bFGF immobilization reaction will be applicable to various polymeric, metallic, and ceramic materials and is a simple strategy to integrate tissue on porous medical devices or scaffolds for tissue regeneration.

    DOI: 10.1002/jbm.a.35516

    Web of Science

    PubMed

    researchmap

  • Single-step immobilization of cell adhesive peptides on a variety of biomaterial substrates via tyrosine oxidation with copper catalyst and hydrogen peroxide. 査読 国際誌

    Sachiro Kakinoki, Tetsuji Yamaoka

    Bioconjugate chemistry   26 ( 4 )   639 - 44   2015年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    Immobilization of biologically active peptides which were isolated from extracellular matrix proteins is a powerful strategy for the design and functionalization of biomaterial substrates. However, the method of peptide immobilization was restricted, that is, peptide is often immobilized through the reactive groups inherent in substrates with multistep reactions. Here, we report a single-step immobilization of fibronectin-derived cell adhesive peptide (Arg-Glu-Asp-Val; REDV) onto polymer materials by use of tyrosine oxidation with copper catalyst and hydrogen peroxide. REDV peptide was successfully immobilized on tissue culture polystyrene, poly(ethylene terephthalate), poly(vinyl chloride), expanded-poly(tetrafluoroethylene), and poly(l-lactic acid), resulting in enhanced adhesion of human umbilical vein endothelial cells. This method is a single-step reaction under very mild conditions and is available for the biological functionalization of various medical devices.

    DOI: 10.1021/acs.bioconjchem.5b00032

    Web of Science

    PubMed

    researchmap

  • Mobility of the Arg-Gly-Asp ligand on the outermost surface of biomaterials suppresses integrin-mediated mechanotransduction and subsequent cell functions. 査読 国際誌

    Sachiro Kakinoki, Ji-Hun Seo, Yuuki Inoue, Kazuhiko Ishihara, Nobuhiko Yui, Tetsuji Yamaoka

    Acta biomaterialia   13   42 - 51   2015年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    Mechanotransduction in the regulation of cellular responses has been previously studied using elastic hydrogels. Because cells interact only with the surface of biomaterials, we are focusing on the molecular mobility at the outermost surface of biomaterials. In this study, surfaces with the mobile Arg-Gly-Asp-Ser (RGDS) peptide have been constructed. Cell culture substrates were coated with ABA-type block copolymers composed of poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) segments (A) and a polyrotaxane (PRX) unit with RGDS bound to α-cyclodextrin (B). Adhesion, morphological changes and actin filament formation of human umbilical vein endothelial cells were reduced on the surfaces containing mobile PRX-RGDS in comparison to the immobile RGDS surfaces constructed from random copolymers with RGDS side groups (Prop-andom-RGDS). In the neurite outgrowth assay using rat adrenal pheochromocytoma cells (PC12), only ∼20% of adherent PC12 cells had neurites on PRX-RGDS surfaces, but more than 50% did on the Random-RGDS surface. The beating colony of dimethyl-sulfoxide-treated mouse embryonic carcinoma cells (P19CL6) were found 10 and 14 days after induction on PRX-RGDS and Random-RGDS surfaces, respectively. After 22 days, the beating colony disappeared on PRX-RGDS surfaces, but many colonies remained on Random-RGDS surfaces. These data suggest that the molecular mobility of the cell-binding ligand on the outermost surface of materials effectively suppresses the actin filament formation and differentiation of these functional cell lines, and may be used as a culture substrate for immature stem cells or progenitor cells.

    DOI: 10.1016/j.actbio.2014.11.020

    Web of Science

    PubMed

    researchmap

  • Directing stem cell differentiation by changing the molecular mobility of supramolecular surfaces. 査読 国際誌

    Ji-Hun Seo, Sachiro Kakinoki, Tetsuji Yamaoka, Nobuhiko Yui

    Advanced healthcare materials   4 ( 2 )   215 - 22   2015年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Polymer surfaces with a wide range of hydrated surface mobility are developed by a simple deposition method with supramolecular block copolymers. The morphologies of adhering stem cells are greatly dependent on the surface mobility of polymers, and this induces significant changes in the cytoskeletal signaling pathway to direct the downstream stem cell differentiation.

    DOI: 10.1002/adhm.201400173

    Web of Science

    PubMed

    researchmap

  • Well-structured Graft-type Phospholipid Polymer for Modified Polyurethane Vascular Prosthesis

    Liu Yihua, Inoue Yuuki, Sakata Sho, Mahara Atsushi, Kakinoki Sachiro, Yamaoka Tetsuji, Ishihara Kazuhiko

    Transactions of the Materials Research Society of Japan   40 ( 2 )   137 - 140   2015年

     詳細を見る

    記述言語:日本語   出版者・発行元:The Materials Research Society of Japan  

    To modify the surface properties of segmented polyurethane (SPU), 2-methacryloyloxyethyl phosphorylcholine (MPC) polymers were applied. We prepared different molecular architectures of the MPC polymers, that is, random-type, block-type, and graft-type to investigate durability of the MPC polymer layer on the SPU. The SPU membranes modified with the MPC polymers were characterized using X-ray photoelectron spectroscopy. The better stability was observed in the poly(MPC-<i>graft</i>-2-ethylhexyl methacrylate (EHMA))(gPMEH) polymer layer on the SPU membrane after immersion in an aqueous medium, the possible reason would be the intermiscibility of the poly(EHMA) segments and the soft segments in the SPU. Each SPU/MPC polymer membrane demonstrated a dramatic suppression of protein adsorption from human plasma. From these results, the antithrombogenicity of the 2.0 mm diameter SPU/gPMEH tubings was investigated. We concluded that the SPU membrane modified with the gPMEH was one of the promising polymeric biomaterials for making blood-contacting medical devices.

    DOI: 10.14723/tmrsj.40.137

    researchmap

  • Water absorbing and quick degradable PLLA/PEG multiblock copolymers reduce the encapsulation and inflammatory cytokine production. 査読

    Tomo Ehashi, Sachiro Kakinoki, Tetsuji Yamaoka

    Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs   17 ( 4 )   321 - 8   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER JAPAN KK  

    Biomaterials that contact with soft tissues such as postoperative adhesion prevention membrane or tissue-regenerative scaffolds should possess specific features such as hydrophilicity, mild to no immunogenicity, and quick degradability. The inflammation reaction to multiblock copolymers of poly(L-lactic acid) (PLLA) and poly(ethylene glycol), named as Multi, which we developed as a good adhesion prevention materials with a very high degradation rate were investigated and compared with usual PLLA, non-degradable polyethylene (PE), and acellular collagenous tissue (COL). Tissue encapsulation, inflammatory cell recruitment, and expression of four cytokines (IL-1β, IL-6, IL-10, and TGFβ) affecting the promotion or inhibition of inflammation and wound healing were evaluated. The thick encapsulation for PE might have related to high expression of TGFβ, and it was largely reduced in the cases of PLLA and Multi. The cytokine expression pattern in PE was dominantly alternatively activated macrophage (M2) type, while expression patterns to Multi were classically activated macrophage (M1)-type dominant, as with the COL specimen. Thus, multi is a tissue compatible material in spite of the large degradability. By introducing low molecular weight PEG into PLLA as multiblock-type sequence, we successfully prepared biocompatible PLLA derivatives with high molecular weight, large degradation rate, and mild tissue responses.

    DOI: 10.1007/s10047-014-0791-z

    Web of Science

    PubMed

    researchmap

  • Thermoresponsive elastin/laminin mimicking artificial protein for modifying PLLA scaffolds in nerve regeneration 査読

    Sachiro Kakinoki, Tetsuji Yamaoka

    Journal of Materials Chemistry B   2 ( 31 )   5061 - 5067   2014年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    Poly(l-lactic acid) (PLLA) is widely used as a scaffold but does not possess biological functions. Here, we described the biosynthesis of the elastin-like repetitive polypeptide (VPGIG)30 containing a laminin-derived neurite outgrowth-promoting sequence (RKRLQVQLSIRT: AG73) (AG73-(VPGIG)30). The expression vector for AG73-(VPGIG)30 was constructed using the self-ligation technique to elongate the VPGIG repetitive sequence. The coacervation temperature of the purified AG73-(VPGIG)30 protein was 20 and 14 °C in water and phosphate-buffered saline (PBS), respectively. AG73-(VPGIG)30 was quickly adsorbed on PLLA films via a hydrophobic interaction by raising the temperature from 4 °C to 37 °C. On the AG73-(VPGIG)30- modified PLLA surface, the neurite outgrowth of PC12 cells was strongly promoted. We successfully induced the neurite outgrowth activity on PLLA films by treating the novel surface modifier AG73-(VPGIG)30, which could be applicable in developing PLLA scaffolds for nerve regeneration. © 2014 the Partner Organisations.

    DOI: 10.1039/c4tb00305e

    Scopus

    researchmap

  • Thermoresponsive elastin/laminin mimicking artificial protein for modifying PLLA scaffolds in nerve regeneration. 査読 国際誌

    Sachiro Kakinoki, Tetsuji Yamaoka

    Journal of materials chemistry. B   2 ( 31 )   5061 - 5067   2014年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROYAL SOC CHEMISTRY  

    Poly(l-lactic acid) (PLLA) is widely used as a scaffold but does not possess biological functions. Here, we described the biosynthesis of the elastin-like repetitive polypeptide (VPGIG)30 containing a laminin-derived neurite outgrowth-promoting sequence (RKRLQVQLSIRT: AG73) (AG73-(VPGIG)30). The expression vector for AG73-(VPGIG)30 was constructed using the self-ligation technique to elongate the VPGIG repetitive sequence. The coacervation temperature of the purified AG73-(VPGIG)30 protein was 20 and 14 °C in water and phosphate-buffered saline (PBS), respectively. AG73-(VPGIG)30 was quickly adsorbed on PLLA films via a hydrophobic interaction by raising the temperature from 4 °C to 37 °C. On the AG73-(VPGIG)30-modified PLLA surface, the neurite outgrowth of PC12 cells was strongly promoted. We successfully induced the neurite outgrowth activity on PLLA films by treating the novel surface modifier AG73-(VPGIG)30, which could be applicable in developing PLLA scaffolds for nerve regeneration.

    DOI: 10.1039/c4tb00305e

    Web of Science

    PubMed

    researchmap

  • Reduced platelets and bacteria adhesion on poly(ether ether ketone) by photoinduced and self-initiated graft polymerization of 2-methacryloyloxyethyl phosphorylcholine. 査読 国際誌

    Takaharu Tateishi, Masayuki Kyomoto, Sachiro Kakinoki, Tetsuji Yamaoka, Kazuhiko Ishihara

    Journal of biomedical materials research. Part A   102 ( 5 )   1342 - 9   2014年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aromatic poly(ether ether ketone) (PEEK) is a super engineering plastic, which has good mechanical properties and is resistant to physical and chemical stimuli. We have, therefore, attempted to use PEEK in cardiovascular devices. Synthetic cardiovascular devices require both high hemocompatibility and anti-inflammatory activity in addition to the mechanical properties. We modified the PEEK surface by photoinduced and self-initiated graft polymerization with 2-methacryloyloxyethyl phosphorylcholine (MPC; PMPC-grafted PEEK) for obtaining good antithrombogenicity. Polymerization was carried out on the surface of PEEK under radiation of ultraviolet (UV) light during which we controlled monomer concentrations, temperatures, and UV intensities. The biological performance of the PMPC-grafted PEEK was examined and compared with that of unmodified PEEK. With increase in the thickness of the PMPC layer, the amount of fibrinogen adsorption decreased significantly in comparison to that in the case of unmodified PEEK. When placed in contact with human platelet-rich plasma, surface of the PMPC-grafted PEEK clearly showed inhibition of platelet adhesion and activation. Also, bacterial adhesion was reduced dramatically on the PMPC-grafted PEEK. Thus, the PMPC grafting on PEEK improved the antithrombogenicity.

    DOI: 10.1002/jbm.a.34809

    Web of Science

    PubMed

    researchmap

  • Durable modification of segmented polyurethane for elastic blood-contacting devices by graft-type 2-methacryloyloxyethyl phosphorylcholine copolymer. 査読 国際誌

    Yihua Liu, Yuuki Inoue, Atsushi Mahara, Sachiro Kakinoki, Tetsuji Yamaoka, Kazuhiko Ishihara

    Journal of biomaterials science. Polymer edition   25 ( 14-15 )   1514 - 29   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TAYLOR & FRANCIS LTD  

    We propose a novel application of 2-methacryloyloxyethyl phosphorylcholine (MPC) polymers for enhancing the performance of modified segmented polyurethane (SPU) surfaces for the development of a small-diameter vascular prosthesis. The SPU membranes were modified by random-type, block-type, and graft-type MPC polymers that were prepared using a double-solution casting procedure on stainless steel substrates. Among these MPC polymers, the graft-type poly(MPC-graft-2-ethylhexyl methacrylate [EHMA]), which is composed of a poly(MPC) segment as the main chain and poly(EHMA) segments as side chains, indicated a higher stability on the SPU membrane after being peeled off from the stainless steel substrate, as well as after immersion in an aqueous medium. This stability was caused by the intermiscibility in the domain of the poly(EHMA) segments and the soft segments of the SPU membrane. Each SPU/MPC polymer membrane exhibited a dramatic suppression of protein adsorption from human plasma and endothelium cell adhesion. Based on these results, the performance of SPU/poly(MPC-graft-EHMA) tubings 2 mm in diameter as vascular prostheses was investigated. Even after blood was passed through the tubings for 2 min, the graft-type MPC polymers effectively protected the blood-contacting surfaces from thrombus formation. In summary, SPU modified by graft-type MPC polymers has the potential for practical application in the form of a non-endothelium, small-diameter vascular prosthesis.

    DOI: 10.1080/09205063.2014.920172

    Web of Science

    PubMed

    researchmap

  • Three-layer microfibrous peripheral nerve guide conduit composed of elastin-laminin mimetic artificial protein and poly(L-lactic acid). 査読 国際誌

    Sachiro Kakinoki, Midori Nakayama, Toshiyuki Moritan, Tetsuji Yamaoka

    Frontiers in chemistry   2   52 - 52   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:FRONTIERS MEDIA SA  

    We developed a microfibrous poly(L-lactic acid) (PLLA) nerve conduit with a three-layered structure to simultaneously enhance nerve regeneration and prevent adhesion of surrounding tissue. The inner layer was composed of PLLA microfiber containing 25% elastin-laminin mimetic protein (AG73-(VPGIG)30) that promotes neurite outgrowth. The thickest middle layer was constructed of pure PLLA microfibers that impart the large mechanical strength to the conduit. A 10% poly(ethylene glycol) was added to the outer layer to prevent the adhesion with the surrounding tissue. The AG73-(VPGIG)30 compositing of an elastin-like repetitive sequence (VPGIG)30 and a laminin-derived sequence (RKRLQVQLSIRT: AG73) was biosynthesized using Escherichia coli. The PLLA microfibrous conduits were fabricated using an electrospinning procedure. AG73-(VPGIG)30 was successfully mixed in the PLLA microfibers, and the PLLA/AG73-(VPGIG)30 microfibers were stable under physiological conditions. The PLLA/AG73-(VPGIG)30 microfibers enhanced adhesion and neurite outgrowth of PC12 cells. The electrospun microfibrous conduit with a three-layered structure was implanted for bridging a 2.0-cm gap in the tibial nerve of a rabbit. Two months after implantation, no adhesion of surrounding tissue was observed, and the action potential was slightly improved in the nerve conduit with the PLLA/AG73-(VPGIG)30 inner layer.

    DOI: 10.3389/fchem.2014.00052

    Web of Science

    PubMed

    researchmap

  • Gene chip/PCR-array analysis of tissue response to 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer surfaces in a mouse subcutaneous transplantation system. 査読 国際誌

    Sachiro Kakinoki, Yusuke Sakai, Taro Takemura, Nobutaka Hanagata, Toshia Fujisato, Kazuhiko Ishihara, Tetsuji Yamaoka

    Journal of biomaterials science. Polymer edition   25 ( 14-15 )   1658 - 72   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TAYLOR & FRANCIS LTD  

    To evaluate the in vivo foreign body reaction to bio-inert 2-methacryloyloxyethyl phosphorylcholine (MPC) polymers, MPC polymer-coated porous substrates, with large surface area, were implanted subcutaneously in mice for 7 and 28 days, and the surrounding tissue response and cells infiltrating into the porous structure were evaluated. The MPC polymer surface induced low angiogenesis and thin encapsulation around the porous substrate, and slightly suppressed cell infiltration into the porous substrate. M1-type macrophage specific gene (CCR7) expression was suppressed by the MPC polymer surface after 7 days, resulting in the suppression of inflammatory cytokine/chemokine gene expression. However, the expression of these genes on the MPC polymer surface was higher than on the non-coated surface after 28 days. These findings suggest that MPC polymer surfaces successfully inhibit inflammatory responses during the early stage of tissue response, and seem to retard its occurrence over time.

    DOI: 10.1080/09205063.2014.939917

    Web of Science

    PubMed

    researchmap

  • Effects of molecular architecture of phospholipid polymers on surface modification of segmented polyurethanes. 査読 国際誌

    Yihua Liu, Yuuki Inoue, Sho Sakata, Sachiro Kakinoki, Tetsuji Yamaoka, Kazuhiko Ishihara

    Journal of biomaterials science. Polymer edition   25 ( 5 )   474 - 86   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TAYLOR & FRANCIS LTD  

    To modify the surface properties of segmented polyurethane (SPU), effects of the molecular architecture of the 2-methacryloyloxyethyl phosphorylcholine (MPC) polymers on the performance of the SPU/MPC polymer membrane were investigated. We combined the random-type, block-type, and graft-type of the MPC polymers with a typical SPU, Tecoflex(®) using double solution casting procedure. The graft-type MPC polymers composed of a poly(MPC) main chain and poly(2-ethylhexyl methacrylate (EHMA)) side chains were synthesized through the combination of two different living radical polymerization techniques to regulate the density and chain length of the side chains. The SPU membranes modified with the MPC polymers were characterized using X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy. The results revealed that the MPC units were located on the SPU surface. Although the breaking strength of the SPU membranes modified with block-type poly(MPC-block-EHMA) and graft-type poly(MPC-graft-EHMA) was lower than that of SPU membranes modified with random-type poly(MPC-random-EHMA), their breaking strengths were adequate for manufacturing medical devices. On the other hand, better stability was observed in the MPC polymer layer on the SPU membrane after immersion in an aqueous medium, wherein the SPU membrane had been modified with the poly(MPC-graft-EHMA). This was because of the intermixing of the hydrophobic poly(EHMA) segments in the domain of the hard segments in the SPU membrane. After this modification, each SPU/MPC polymer membrane showed hydrophilic nature based on the MPC polymers and a dramatic suppression of protein adsorption. From these results, we concluded that the SPU membrane modified with the poly(MPC-graft-EHMA) was one of the promising polymeric biomaterials for making blood-contacting medical devices.

    DOI: 10.1080/09205063.2013.873282

    Web of Science

    PubMed

    researchmap

  • Elastic/adhesive double-layered PLA-PEG multiblock copolymer membranes for postoperative adhesion prevention

    Tetsuji Yamaoka, Ellyana Njatawidjaja, Atsushi Kasai, Carlos Alberto Agudelo, Tomo Ehashi, Sachiro Kakinoki, Satoshi Kato, Atsushi Mahara

    POLYMER DEGRADATION AND STABILITY   98 ( 11 )   2168 - 2176   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    Tissue adhesions cause severe and life-threatening conditions, including pain, infertility, and heart defects. The purpose of this study is to develop an anti-adhesion membrane that sticks onto the injured tissues or organs in order to avoid the suturing of the membrane which may lead to the unnecessary tissue adhesion. We previously developed poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) multiblock copolymers as soft, water absorbable, and quickly degradable biomaterials. The copolymer with the highest PEG content adsorbs body fluid in vivo and sticks to the tissues. In the present study thin film and nanofiber mat were prepared from the copolymer and evaluated in vitro and in vivo. The hydrophilicity and the degradation rate increased with the increased PEG content of the multiblock copolymers. The copolymer with PEG content of 88% (LE(m)-88) was quickly swollen, become viscous, and rapidly collapsed in PBS, which was suitable feature for adhesion prevention material without suturing. Various double layered membranes with different characteristics were evaluated in vivo by applying onto the cecum scrubbed with abrasive paper, and onto the heart surface after pericardium removal. LE(m)-88 was swollen with tissue fluid and had a hydrogel-like nature. LE(m)-88 film/LE(m)-32 film double layered membrane was found to be the most effective in preventing tissue adhesion in cecum model. This excellent performance was confirmed in the rat heart adhesion model. In both models, the LE(m)-32 support film was detached from the site of application, which leads to the healing without adhesion. (C) 2013 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.polymdegradstab.2013.08.026

    Web of Science

    researchmap

  • Platelet responses to dynamic biomaterial surfaces with different poly(ethylene glycol) and polyrotaxane molecular architectures constructed on gold substrates. 査読 国際誌

    Sachiro Kakinoki, Nobuhiko Yui, Tetsuji Yamaoka

    Journal of biomaterials applications   28 ( 4 )   544 - 51   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SAGE PUBLICATIONS LTD  

    Four different dynamic biomaterial surfaces with different molecular architectures were prepared using two hydrophilic polymers: poly(ethylene glycol) and polyrotaxanes containing α-cyclodextrin. Either one or both terminals of the poly(ethylene glycol) or polyrotaxanes were immobilized onto a gold substrate via Au-S bonds, resulting in poly(ethylene glycol)-graft, polyrotaxanes-graft, poly(ethylene glycol)-loop, and polyrotaxanes-loop structures. Human platelet adhesion was suppressed more effectively on the graft surfaces than on the loop surfaces for both poly(ethylene glycol) and polyrotaxanes due to the high mobility of graft polymer chains with a free terminal. Moreover, the platelets adhered to the polyrotaxane surfaces much less than the poly(ethylene glycol) surfaces, possibly because of the mobile nature of the α-cyclodextrin molecules that were threaded on the poly(ethylene glycol) chain. Actin filament assembly in adherent platelets was also greatly prevented on the poly(ethylene glycol)/polyrotaxanes-graft surfaces in comparison with the corresponding loop surfaces. A clear correlation between the numbers and areas of adherent platelets on these surfaces suggests that platelet adhesion and activation were dominated by the platelet GPIIb/IIIa-adsorbed fibrinogen interaction. These results indicate that both of the different modes of dynamic features, sliding/rotation of α-cyclodextrin and polymer chain mobility, effectively suppressed platelet adhesion in spite of the similar hydrophilicity. This research affords a novel chemical strategy for designing hemocompatible biomaterial surfaces.

    DOI: 10.1177/0885328212462260

    Web of Science

    PubMed

    researchmap

  • Inducing rapid cellular response on RGD-binding threaded macromolecular surfaces. 査読 国際誌

    Ji-Hun Seo, Sachiro Kakinoki, Yuuki Inoue, Tetsuji Yamaoka, Kazuhiko Ishihara, Nobuhiko Yui

    Journal of the American Chemical Society   135 ( 15 )   5513 - 6   2013年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    The rapid response of integrin β1 molecules to an RGD peptide on a dynamic polyrotaxane surface was successfully induced. As a result, RGD peptides introduced on a highly dynamic cyclodextrin molecule enhanced the frequency of contact with specific integrin molecules on the cell membrane at the early stage of material-cell interactions.

    DOI: 10.1021/ja400817q

    Web of Science

    PubMed

    researchmap

  • The significance of hydrated surface molecular mobility in the control of the morphology of adhering fibroblasts. 査読 国際誌

    Ji-Hun Seo, Sachiro Kakinoki, Yuuki Inoue, Kwangwoo Nam, Tetsuji Yamaoka, Kazuhiko Ishihara, Akio Kishida, Nobuhiko Yui

    Biomaterials   34 ( 13 )   3206 - 14   2013年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    The effects of the hydrated molecular mobility and the surface free energy of polymer surfaces on fibronectin adsorption and fibroblast adhesion were investigated. ABA-type block copolymers composed of polyrotaxane (PRX) with different number of threaded α-cyclodextrin (α-CD), random copolymers with similar chemical composition to the PRX block copolymers, and conventional polymers were prepared to determine a wide range of hydrated molecular mobility (Mf) values estimated by quartz crystal microbalance-dissipation (QCM-D) measurements. Fibronectin adsorption was highly dependent on surface free energy, and high surface fibronectin density resulted in a large projected cell area on the polymer surfaces. However, the morphology of adhering fibroblasts was not explained by the surface free energy, but it was found to be strongly dependent on the Mf values of the polymer surfaces in aqueous media. These results emphasize the importance of Mf in the discussion of the elongated morphology of adhering fibroblasts on various polymer surfaces.

    DOI: 10.1016/j.biomaterials.2013.01.080

    Web of Science

    PubMed

    researchmap

  • MicroRNA 210 as a biomarker for congestive heart failure. 査読

    Kosuke Endo, Yukiko Naito, Xu Ji, Michio Nakanishi, Teruo Noguchi, Yoichi Goto, Hiroshi Nonogi, Xiao Ma, Huachun Weng, Go Hirokawa, Takashi Asada, Sachiro Kakinoki, Tetsuji Yamaoka, Yasue Fukushima, Naoharu Iwai

    Biological & pharmaceutical bulletin   36 ( 1 )   48 - 54   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PHARMACEUTICAL SOC JAPAN  

    MicroRNAs (miRNAs) are endogenous small RNAs that are 18-23 nucleotides long. Recently, plasma miRNAs were reported to be sensitive and specific biomarkers of various pathological conditions. In the present study, we focused on miR-210, which is known to be induced by hypoxia and might therefore be an excellent biomarker for congestive heart failure. Plasma miR-210 levels and expression levels in mononuclear cells and skeletal muscles were elevated in Dahl salt-sensitive rats with heart failure. We also assessed miR-210 expression in patients with heart failure. The miR-210 expression levels in the mononuclear cells of patients with NYHA III and IV heart failure according to the New York Heart Association (NYHA) functional classification system were significantly higher than those with NYHA II heart failure and controls. Although no significant correlation was observed between plasma brain natriuretic peptide (BNP) and plasma miR-210 levels in patients with NYHA II heart failure, patients with an improved BNP profile at the subsequent hospital visit were classified in a subgroup of patients with low plasma miR-210 levels. Plasma miR-210 levels may reflect a mismatch between the pump function of the heart and oxygen demand in the peripheral tissues, and be a new biomarker for chronic heart failure in addition to plasma BNP concentrations.

    Web of Science

    PubMed

    researchmap

  • Movable Polyrotaxane Surfaces for Modulating Cellular Adhesion via Specific RGD-Integrin Binding

    Ji-Hun Seo, Sachiro Kakinoki, Tetsuji Yamaoka, Nobuhiko Yui

    BIOMEDICAL APPLICATIONS OF SMART TECHNOLOGIES   86   59 - +   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)   出版者・発行元:TRANS TECH PUBLICATIONS LTD  

    Immobilizing bioactive molecules on the materials surfaces is one of the main strategies for creating functional bio-interfaces. In these kinds of bio-interfaces, the density of immobilized functional groups and the following physicochemical factors such as roughness, polarity and electrical charge have been thought important variables for regulating biological responses such as cell adhesion and differentiations. Here in this study, differences between rigidity and dynamically immobilized bioactive molecules on the biological responses will be discussed. In order to develop dynamic bio-interfaces, a polyrotaxane based block-copolymer containing clickable azide groups for conjugating various bioactive molecules was designed. Cell adhesive RGD peptide was then conjugated with the azide group by click reaction on both dynamic and rigid surfaces. As a result, cell adhesive RGD peptide immobilized on the dynamic bio-interfaces shows larger initial cell adhesion area, indicating that molecular dynamics of surface chemical groups is another important variable for the regulation of biological responses.

    DOI: 10.4028/www.scientific.net/AST.86.59

    Web of Science

    researchmap

  • A large mobility of hydrophilic molecules at the outmost layer controls the protein adsorption and adhering behavior with the actin fiber orientation of human umbilical vein endothelial cells (HUVEC). 査読 国際誌

    Sachiro Kakinoki, Ji-Hun Seo, Yuuki Inoue, Kazuhiko Ishihara, Nobuhiko Yui, Tetsuji Yamaoka

    Journal of biomaterials science. Polymer edition   24 ( 11 )   1320 - 32   2013年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TAYLOR & FRANCIS LTD  

    Adhesion behaviors of human umbilical vein endothelial cells (HUVECs) are interestingly affected by the mobility of hydrophilic chains on the material surfaces. Surfaces with different molecular mobilities were prepared using ABA-type block copolymers consisting polyrotaxane (PRX) or poly(ethylene glycol) (PEG) central block (A block), and amphiphilic anchoring B blocks of poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) (PMB). Two different molecular mobilities of the PRX chains were designed by using normal α-cyclodextrin (α-CD) or α-CD whose hydroxyl groups were converted to methoxy groups in a given ratio to improve its molecular mobility (PRX-PMB and OMe-PRX-PMB). The surface mobility of these materials was assessed as the mobility factor (Mf), which is measured by quartz crystal microbalance with dissipation monitoring system. HUVECs adhered on OMe-PRX-PMB surface much more than PRX-PMB and PMB-block-PEG-block-PMB (PEG-PMB) surfaces. These different HUVEC adhesions were correlated with the density of cell-binding site of adsorbed fibronectin. In addition, the alignment of the actin cytoskeleton of adhered HUVECs was strongly suppressed on the PEG-PMB, PRX-PMB, and OMe-PRX-PMB in response to the increased Mf value. Remarkably, the HUVECs adhered on the OMe-PRX-PMB surface with much less actin organization. We concluded that not only the cell adhesion but also the cellular function are regulated by the molecular mobility of the outmost material surfaces.

    DOI: 10.1080/09205063.2012.757726

    Web of Science

    PubMed

    researchmap

  • Designing dynamic surfaces for regulation of biological responses

    Ji-Hun Seo, Sachiro Kakinoki, Yuuki Inoue, Tetsuji Yamaoka, Kazuhiko Ishihara, Nobuhiko Yui

    SOFT MATTER   8 ( 20 )   5477 - 5485   2012年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROYAL SOC CHEMISTRY  

    ABA block copolymers composed of highly methylated polyrotaxane and hydrophobic anchoring terminal segments containing 2-methacryloyloxyethyl phosphorylcholine (MPC) and n-butyl methacrylate (PMB) (OMe-PRX-PMB) were synthesized as a platform of molecularly dynamic biomaterials. A contact angle measurement indicated that polymer surfaces with higher molecular mobility factors (M-f) estimated from quartz crystal microbalance with dissipation (QCM-D) measurements showed more significant changes in hydrophilicity in response to an environmental change between air and water; the OMe-PRX-PMB surface showed the highest M-f among the prepared polymer surfaces. Fibrinogen adsorption and its conformational analysis estimated by QCM-D and enzyme-linked immunosorbent assay revealed that large amounts of fibrinogen adsorption occurred in a soft manner on the OMe-PRX-PMB surface and that the antibody binding to the C-terminus of the fibrinogen gamma chains responsible for platelet adhesion and activation decreased as the M-f value increased. Furthermore, it was found that the OMe-PRX-PMB surface showed low platelet adhesion and high fibroblast adhesion, suggesting that molecular movement on biomaterial surfaces could be one of the key parameters in the regulation of a non-specific biological response.

    DOI: 10.1039/c2sm25318f

    Web of Science

    researchmap

  • Surface Modification of Poly(L-lactic acid) Nanofiber with Oligo(D-lactic acid) Bioactive-Peptide Conjugates for Peripheral Nerve Regeneration

    Sachiro Kakinoki, Sho Uchida, Tomo Ehashi, Akira Murakami, Tetsuji Yamaoka

    POLYMERS   3 ( 2 )   820 - 832   2011年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    In some traumatic nerve injuries, autologous nerve grafting is the first choice for bridging the gap between the severed nerve ends. However, this therapeutic strategy has some disadvantages, including permanent loss of donor function and requirement of multiple surgeries. An attractive alternative to this therapeutic technique is the use of artificial nerve conduit. Poly (L-lactic acid) (PLLA) is widely used as a substrate for artificial nerve conduit because it is readily biodegradable, but it is not inherently biologically active. In this study, we developed a PLLA nanofibrous nerve conduit, modified with a conjugate of oligo (D-lactic acid) (ODLA) and the neurite outgrowth, thereby promoting peptide AG73 (RKRLQVQLSIRT) to improve nerve regeneration. PLA/ODLA-AG73 nanofibrous conduit was fabricated by electrospinning and then transplanted at the 10 mm gap of rat sciatic nerve. After six months, electrophysiological evaluation revealed that it achieved better functional reinnervation than silicone tube (used as a reference) or unmodified PLLA nanofibrous conduit.

    DOI: 10.3390/polym3020820

    Web of Science

    researchmap

  • Stable modification of poly(lactic acid) surface with neurite outgrowth-promoting peptides via hydrophobic collagen-like sequence. 査読 国際誌

    Sachiro Kakinoki, Tetsuji Yamaoka

    Acta biomaterialia   6 ( 6 )   1925 - 30   2010年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    Surface modification of poly(dl-lactic acid) (PLA) scaffolds has been performed using a biofunctional small peptide composed of collagen-like repetitive sequence and laminin-derived sequence (AG73-G(3)-(PPG)(5)) via hydrophobic interaction. The results of surface analysis suggest that AG73-G(3)-(PPG)(5) can be stably adsorbed onto PLA films via hydrophobic interaction at the (PPG)(5) region, and form an extracellular matrix-like layer composed of both structural and biosignalling sequences. In addition, neurite outgrowth of PC12 cells was observed on the AG73-G(3)-(PPG)(5)-adsorbed PLA film. These results indicate that AG73-G(3)-(PPG)(5) very effectively enhances neurite outgrowth activity on PLA films. The hydrophobic adsorption of collagen-like peptide bound to biosignalling molecules may be widely applied as a surface modifier of PLA films for tissue engineering.

    DOI: 10.1016/j.actbio.2009.12.001

    Web of Science

    PubMed

    researchmap

  • In vivo evaluation of microspheres containing the angiogenesis inhibitor, TNP-470, and the metastasis suppression with liver metastatic model implanted neuroblastoma. 査読 国際誌

    Chikao Yasuda, Shoei Sakata, Sachiro Kakinoki, Yoshifumi Takeyama, Harumasa Ohyanagi, Hitoshi Shiozaki

    Pathophysiology : the official journal of the International Society for Pathophysiology   17 ( 2 )   149 - 55   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    TNP-470 (AGM-1470, O-(chloroacetylcarbamoyl) fumagillol), which strongly inhibits the angiogenesis, is promising as a new drug for tumor dormancy therapy; however, TNP-470 is very unstable in vitro and in vivo. We previously prepared TNP-470 containing microspheres composed of poly (lactic acid) with medium-chain triglyceride, and demonstrated that the microspheres released TNP-470 over the long-term in vitro. The present study was undertaken to evaluate the release profile of TNP-470 in vivo and the inhibitory effect on hepatic metastasis of neuroblastoma. It was found that the microspheres could maintain high levels of TNP-470 in the blood plasma for over 4 weeks in vivo. In addition, hepatic metastasis of neuroblastoma was strongly inhibited at 2 weeks after intraperitoneal injection of the microspheres. Following 2 weeks of treatment, the liver weights of mice injected with TNP-DDS (TNP-DDS (H), and TNP-DDS (L) groups) and those injected with only physiological saline (C-1300 group) after implantation of neuroblastoma cells were 1.18+/-0.13g, 1.28+/-0.10g, and 2.54+/-0.97g, respectively (p<0.05; C-1300 group compared with the TNP-DDS (H) and the TNP-DDS (L) groups, respectively). It was evident that microspheres containing TNP-470 have an excellent potential for clinical application in tumor dormancy therapy.

    DOI: 10.1016/j.pathophys.2009.04.003

    Scopus

    PubMed

    researchmap

  • Surface modification of SUS316L stainless steel with tartaric acid derivative-crosslinked human serum albumin matrices 査読

    Sachiro Kakinoki, Yasuyuki Katada, Yoshiyuki Uchida, Tetsushi Taguchi

    The Open Biotech. J.   2, 143-147   2008年

     詳細を見る

  • Antitumor effect of an injectable in-situ forming drug delivery system composed of a novel tissue adhesive containing doxorubicin hydrochloride. 査読 国際誌

    Sachiro Kakinoki, Tetsushi Taguchi

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V   67 ( 3 )   676 - 81   2007年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Our group has developed a novel tissue adhesive composed of biomacromolecules and organic acid derivatives which have good biocompatibility and exhibit high bonding strength to living tissues. We propose to use this tissue adhesive for in-situ forming drug delivery system (DDS) for cancer chemotherapy. In a previous work, we had prepared a novel in-situ forming DDS composed of human serum albumin (HSA) and tartaric acid derivative (TAD) containing doxorubicin hydrochloride (DOX), and we had demonstrated an in vitro release profile of DOX from HSA-TAD gel for approximately up to 100h. Here, we report on antitumor effect of this injectable in-situ forming DDS. Local injection of DOX by the HSA-TAD was administered to human colon carcinoma (WiDr) implanted subcutaneously onto the immunodeficient mouse. The results of the in vivo experiments showed that the presence of DOX in blood of mice was detectable for up to 3days, and that the tumor volume was effectively minimized with injection of HSA-TAD containing DOX. The in-situ forming DDS with the novel tissue adhesive containing DOX, therefore, is a useful technique for cancer chemotherapy.

    DOI: 10.1016/j.ejpb.2007.03.020

    Web of Science

    PubMed

    researchmap

  • Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: characterization and in vitro evaluation. 査読 国際誌

    Sachiro Kakinoki, Tetsushi Taguchi, Hirofumi Saito, Junzo Tanaka, Tetsuya Tateishi

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V   66 ( 3 )   383 - 90   2007年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Injectable polymers that are biocompatible and biodegradable are important biomaterials for drug delivery system (DDS) and tissue engineering. We have already developed novel tissue adhesives consisting of biomacromolecules and organic acid derivatives with active ester groups. The resulting tissue adhesive forms in situ as a gel and has high bonding strength for living tissue as well as it has good biocompatibility and biodegradability. Here, we report on the physicochemical properties and in vitro evaluation of this novel tissue adhesive consisting of human serum albumin (HSA) and tartaric acid derivative (TAD) containing doxorubicin hydrochloride (DOX). The results of the measurement of physicochemical characteristics indicate that the gelation time and gel strength of HSA-TAD gels can be controlled according to the material composition. The bonding strength of HSA-TAD adhesives was found to be sufficient to adhere at focus and to correspond with the cross-linking density of HSA-TAD gels. Furthermore, the release of DOX from HSA-TAD gels was sustained for approximately 100 h in an in vitro evaluation. The novel tissue adhesive, therefore, is expected to be applicable for use as an injectable in situ forming DDS.

    DOI: 10.1016/j.ejpb.2006.11.022

    Web of Science

    PubMed

    researchmap

  • Development of a novel glue consisting of naturally-derived biomolecules: citric acid and human serum albumin. 査読 国際誌

    Tetsushi Taguchi, Hirofumi Saito, Masashi Iwasashi, Masataka Sakane, Sachiro Kakinoki, Naoyuki Ochiai, Junzo Tanaka

    Journal of nanoscience and nanotechnology   7 ( 3 )   742 - 7   2007年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SCIENTIFIC PUBLISHERS  

    A novel glue consisting of human serum albumin (HSA) and citric acid derivative (CAD) was developed where the glue is named as CAD-A glue. In this adhesive, CAD works as a crosslinking reagent of HSA. For preparing crosslinking reagent CAD, using citric acid as a starting material, three carboxyl groups of a citric acid were modified with N-hydroxysuccinimide in the presence of 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride. From 1H-NMR spectrum, CAD with three active ester groups in a molecule was successfully synthesized with a high yield (more than 80%). The boding time of CAD-A glue to collagen-based casing was saturated within 15 minutes. The bonding strength of this glue to collagen-based casings increased with increasing of HSA concentration. The maximum bonding strength of CAD-A glue was a slightly low level compared to the bonding strength of cyanoacrylate adhesive and was 9 times higher than that of fibrin glue. The CAD-A glue showed excellent biocompatibility and high ability of wound closure similar to that of cyanoacrylate-based adhesive when glues were applied to the mouse skin. These results suggested that this developed adhesive had both tissue compatibility and bonding strength for use in clinical field.

    DOI: 10.1166/jnn.2007.515

    Web of Science

    PubMed

    researchmap

  • Solution property and irradiation effect of random copolypeptides composed of Ala and Pro residues

    Sachiro Kakinoki, Makoto Kitamura, Mitsuhiro Yuge, Masakazu Furuta, Masahito Oka, Yoshiaki Hirano, Kenji Kono, Isao Kaetsu

    POLYMER BULLETIN   58 ( 2 )   393 - 400   2007年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Poly(proline) and random copolypeptide composed of Pro and Ala residues were synthesized, and their solution properties and molecular conformation were investigated. Aqueous solutions of the polypeptide were irradiated with gamma-rays above the transition temperature. It was shown that the transition temperature of the aqueous solution of the copolypeptide is influenced by Ala-residue content and gamma-ray irradiation.

    DOI: 10.1007/s00289-006-0666-4

    Web of Science

    researchmap

  • Development of biocompatible glue for minimum invasive therapy

    T. Taguchi, H. Saito, M. Iwasashi, M. Sakane, S. Kakinoki, N. Ochiai, T. Tateishi

    BIOCERAMICS, VOL 19, PTS 1 AND 2   330-332   1339 - +   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(国際会議プロシーディングス)   出版者・発行元:TRANS TECH PUBLICATIONS LTD  

    A biocompatible glue consisting of human serum albumin (HSA) and citric acid derivative (CAD), named CAD-A glue was developed. CAD was successfully synthesized by the reaction between citric acid and N-hydroxysuccinimide in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride. When the CAD-A glue was applied to the collagen-based casings, it took 7 min to obtain half of maximum bonding strength (760 g/cm2). The bonding strength of this glue to collagen-based casings increased with increasing of HSA concentration. The bonding strength of CAD-A glue increased with increasing CAD concentration up to 200 mM, and then decreased with increasing CAD concentration under the fixed HSA concentration (50 w/w%). The CAD-A glue showed excellent wound closure ability rather than fibrin glue when applied to the mouse skin. These results suggested that this developed glue had both tissue compatibility and bonding strength for use in clinical field.

    Web of Science

    researchmap

  • Synthesis of novel crosslinkers for promoting spheroid formation 査読

    Ito Michiko, Taguchi Tetsushi, Kakinoki Sachiro, Kobayashi Hisatoshi, Tanaka Junzo

    TISSUE ENGINEERING   12 ( 4 )   1078   2006年4月

  • Thermosensitive properties of poly(proline)-based polypeptide having an amino-acid of low hydrophobicity

    M Kitamura, S Kakinoki, Y Hirano, M Oka

    POLYMER BULLETIN   54 ( 4-5 )   303 - 310   2005年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Several types of poly(Gly-co-Pro) and poly(Ala-co-Pro) were synthesized. Their molecular conformations and thermosensitive properties were investigated in an attempt to find new thermosensitive materials. These polypeptides were assumed the polyproline-II structure in the temperature range of 20 to 80 degrees C. They also exhibited cloud points in light transmittance, indicating the phase transition. The transition temperatures increased with decrease in hydrophobicity of the polypeptides, that is, in the order poly(proline), poly(Ala-co-Pro) and poly(Gly-co-Pro).

    DOI: 10.1007/s00289-005-0384-3

    Web of Science

    researchmap

  • On the stability of polyproline-I and II structures of proline oligopeptides

    S Kakinoki, Y Hirano, M Oka

    POLYMER BULLETIN   53 ( 2 )   109 - 115   2005年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Proline oligopeptides composed of 13, 6 and 4 Pro residues were synthesized by solid-phase procedure. The circular dichroism spectra showed that the proline oligopeptides form the polyproline-II helix in water and in trifluoroethnol. However, it was shown that the oligopeptide composed of 13 Pro residues remarkably presents conformational transition from the polyproline-II to the polyproline-I helix in methanol and 1-propanol. This result is the first spectrum evidence that proline oligopeptides can form the polyproline-I helix in pure aliphatic alcohol such as methanol and 1-propanol. It was also shown that the propensity forming polyproline-I helix is more favorable in 1-propanol than in methanol, and also that the longer the chain-length is, the greater the stability of the polyproline-I helix is. Such a chain-length dependency of the conformational stability is also supported by the theoretical calculation using molecular mechanics.

    DOI: 10.1007/s00289-004-0317-6

    Web of Science

    researchmap

  • Temperature and pH responsiveness of poly-(DMAA-co-unsaturated carboxylic acid) hydrogels, synthesized by UV-irradiation

    S Kakinoki, Kaetsu, I, M Nakayama, K Sutani, K Uchida, K Yukutake

    RADIATION PHYSICS AND CHEMISTRY   67 ( 5 )   685 - 693   2003年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Stimuli-responsive polyampholyte hydrogels were synthesized by the copolymerization of dimethylaminoethyl methacrylate (DMAA) and acrylic acid (AAc) or itaconic acid (IAc) by UV-irradiation. Temperature and pH responsiveness of these hydrogels were studied. The temperature responsiveness of poly-(DMAA-co-AAc, lAc) hydrogels shown in change of water content became dull compared to that of DMAA homo-polymer hydrogel. The water content of the poly-(DMAA-co-AAc, IAc) hydrogels showed a minimum at pH 8, and increased in more acidic and alkaline regions. This fact can be attributed to the coexistence of anions and cations in the poly-(DMAA-co-AAc, lAc) hydrogels. The poly-(DMAA-co-AAc, IAc) hydrogels were polyampholyte having both temperature responsiveness and pH responsiveness. (C) 2002 Elsevier Science Ltd. All rights reserved.

    Web of Science

    researchmap

  • Preparation of poly-lactic acid microspheres containing the angiogenesis inhibitor TNP-470 with medium-chain triglyceride and the in vitro evaluation of release profiles. 査読 国際誌

    Sachiro Kakinoki, Chikao Yasuda, Isao Kaetsu, Kumao Uchida, Kouji Yukutake, Masashi Nakayama, Satoru Fujiie, Daisuke Kuroda, Michio Kato, Harumasa Ohyanagi

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V   55 ( 2 )   155 - 60   2003年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    TNP-470 (AGM-1470, 6-0-(N-chloroacetylcarbamoyl)-fumagillol), a derivative of fumagillin, is a promising angiogenesis inhibitor. However, as TNP-470 is very unstable in in vitro and in vivo, it has been difficult to verify its pharmacological efficacy in the clinical medicine. The preparation of a drug delivery system (DDS) in a microsphere form was studied for the stable inclusion and controlled release of TNP-470. Medium-chain triglyceride (MCTG) as an effective stabilizer and poly-lactic acid (PLA) as a biodegradable carrier were used for this purpose. The release of TNP-470 from the MCTG containing DDS continued for approximately 2 weeks, while the release of TNP-470 from the one without MCTG stopped after only 5 days. It was proved that TNP-470 could be released much more stable for much longer period from the MCTG containing DDS compared to the one without DDS.

    DOI: 10.1016/S0939-6411(02)00156-X

    Web of Science

    PubMed

    researchmap

  • The preparation of the chronic hyper-endotoxemia experimental animal model by means of a drug delivery system

    S Kakinoki, K Yukutake, Kaetsu, I, K Uchida, K Sutani, T Kosumi, N Usui, T Yonekura, A Kubota, H Ohyanagi

    JOURNAL OF CONTROLLED RELEASE   75 ( 1-2 )   167 - 172   2001年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    A drug delivery system (DDS) consisting of lipopolysaccharide (LPS) as a drug and 2-hydroxyethyl methacrylate (HEMA)-diethylene glycol dimethacrylate (2G) or -polyethylene glycol dimethacrylate (4G, 9G) copolymer was prepared, and used for the efficient preparation of an experimental animal model of chronic hyper-endotoxemia. The release profiles of LPS in the in-vitro test were greatly influenced by the composition of HEMA-2G, 4G, 9G in the copolymer. It was found that LPS release from the DDS continued gradually and constantly throughout 2 weeks. In the in-vivo experiment with rats, the DDS maintained a high blood concentration level of LYS for 3 days. These results strongly suggest the possibility of convenient and reproducible preparation of a chronic hyper-endotoxemia animal model. (C) 2001 Elsevier Science BY All rights reserved.

    Web of Science

    researchmap

  • Application of a drug delivery system in a novel rat model of chronic hyperendotoxemia

    T Kosumi, N Usui, A Kubota, H Hoki, K Yamauchi, T Nogami, H Ohyanagi, T Yonekura, S Hirooka, S Kakinoki, Kaetu, I

    PEDIATRIC SURGERY INTERNATIONAL   17 ( 4 )   321 - 325   2001年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER-VERLAG  

    There has not: been an ideal reproducible small-animal model of chronic hyperendotoxemia to date. Our drug delivery system (DDS) is a new technology that call deliver a drug conveniently to a target organ at an optional rate. 2-Hydroxyethyl methacrylate (HEMA) was used as a carrier of lipopolysaccharide (LPS), and diethylene glycol and polyethylene glycol dimethacrylates (2G, 4G, 9G) were used as cross-linking agents. A mixed solution of HEMA and di(poly)ethylene glycol dimethacrylate was charged into a glass tube with or without LPS and polymerized by ultraviolet irradiation. This polymer was cut into DDS tablets of the same size with or without LPS. A mixture with HEMA:4G = 1:3 was the most suitable composition to release a constant concentration of LPS. We also developed a novel rat model of chronic hyperendotoxemia. Four DDS tablets, each containing 15 mg LPS, were implanted into the abdominal cavity of rats in the LPS group. The control group was implanted with four DDS tablets without: LPS. Plasma levels of LPS in the study group were maintained at more than 2,000 pg/ml for 72 h after implantation. Weight gain was lower and body temperature was higher in the LPS group than in the control group. Plasma levels of inter leukin (IL)-6 in the LPS group were higher than in the control group only during the initial 12 h after implantation of DDS tablets. The white blood cell count at 24 h and platelet counts at 24, 48, and 72 h in the LPS group were lower than these in the control group. These results indicate that chronic hyperendotoxemia was maintained for 72 h by continuous release of LPS from the DDS. Moreover, the intensity of endotoxemia could be varied by varying the number of DDS tablets. It is concluded that our new rat model using LPS-DDS will be applicable and useful as a model of chronic hyperendotoxemia.

    Web of Science

    researchmap

▼全件表示

書籍等出版物

  • 神経

    柿木 佐知朗, 山岡 哲二( 担当: 共著)

    再生医療における臨床研究と製品開発  2013年 

     詳細を見る

  • 人工臓器の終わりなき挑戦(3) 免疫応答・炎症反応、さらに生体適合の謎に迫る

    柿木 佐知朗( 担当: 単著)

    人工臓器は、いま  2013年 

     詳細を見る

    人工臓器学会編

    researchmap

  • バイオロジカルスキャホールドと脱細胞組織

    山岡 哲二, 柿木 佐知朗, 馬原 淳( 担当: 共著)

    再生医療叢書【2】組織工学  2013年 

     詳細を見る

    日本再生医療学会監修, 岡野光夫・大和雅之編集

    researchmap

  • 免疫と炎症

    柿木 佐知朗, 山岡 哲二( 担当: 共著)

    先端バイオマテリアルハンドブック  2012年 

     詳細を見る

    石原一彦、秋吉一成、山岡哲二編

    researchmap

  • 再生医療のための繊維材料修飾とその評価

    山岡 哲二, 柿木 佐知朗( 担当: 共著)

    繊維と工業  2012年 

     詳細を見る

  • ステント(3):ステントの新展開

    柿木 佐知朗, 山岡 哲二( 担当: 共著)

    バイオマテリアル-生体材料  2011年 

     詳細を見る

  • 体に優しい医療用接着剤

    柿木 佐知朗, 田口 哲志( 担当: 共著)

    ケミカルエンジニアリング  2006年 

     詳細を見る

▼全件表示

MISC

  • Effect of dynamic polyrotaxane coating on cytoskeletal signaling expression of adhering stem cells and downstream differentiations. 査読

    Ji Hun Seo, Mitsuhi Hirata, Sachiro Kakinoki, Tetsuji Yamaoka, Nobuhiko Yui

    Advances in Science and Technology   102   37 - 42   2017年1月

     詳細を見る

    記述言語:英語   掲載種別:記事・総説・解説・論説等(学術雑誌)  

    DOI: 10.4028/www.scientific.net/AST.102.37

    researchmap

  • 抗血栓性処理PEEK製機械弁の創出とワーファリンフリー生涯型弁への挑戦

    神戸裕介, 田中裕史, 馬原淳, 深澤今日子, 塩島太郎, ムニッソ マリアキアラ, 柿木佐知朗, 染川将太, 村越成恵, 徳重恭之, 迎田拓也, 北川和宜, 湊谷謙司, 石原一彦, 山岡哲二

    高分子学会医用高分子シンポジウム講演要旨集   45th   2016年

     詳細を見る

  • Electrospun Micro-Fibrous Conduits Composed of Poly(l-lactic Acid) and Elastin-Laminin Mimicking Protein for Peripheral Nerve Regeneration

    S. Kakinoki, M. Nakayama, T. Moritan, T. Yamaoka

    TISSUE ENGINEERING PART A   20   S3 - S3   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MARY ANN LIEBERT, INC  

    DOI: 10.1089/ten.tea.2014.5001.abstracts

    Web of Science

    researchmap

  • ePTFEへのフィブロネクチン由来ペプチドの固定化と内皮細胞接着性の向上

    柿木佐知朗, 馬原淳, 山岡哲二

    人工臓器(日本人工臓器学会)   43 ( 2 )   2014年

     詳細を見る

  • REDV-Bearing Stent : One Step Immobilization of Tyr Containing Peptides onto Biomaterial Surfaces

    KAKINOKI Sachiro, TAKASAKI Kensuke, HIRANO Yoshiaki, YAMAOKA Tetsuji

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2012   109 - 110   2013年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • 再生医療のための繊維材料修飾とその評価

    山岡 哲二, 柿木 佐知朗

    Fiber = 繊維学会誌 : journal of the Society of Fiber Science and Technology, Japan   68 ( 11 )   314 - 318   2012年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:繊維学会  

    DOI: 10.2115/fiber.68.P_314

    Web of Science

    researchmap

  • 人工細胞外基質よりなる神経誘導管を用いた末梢神経再生

    柿木 佐知朗

    人工臓器   41 ( 1 )   53 - 54   2012年6月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • Biological responses on the dynamic surfaces prepared by supramolecular block copolymers

    Ji-Hun Seo, Sachiro Kakinoki, Tetsuji Yamaoka, Nobuhiko Yui

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   243   2012年3月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER CHEMICAL SOC  

    Web of Science

    researchmap

  • 高分子多孔質スキャホールドの埋入が誘起する炎症反応の遺伝子網羅的解析

    柿木佐知朗, 柿木佐知朗, 坂井勇亮, 坂井勇亮, 竹村太郎, 花方信孝, 藤里俊哉, 石原一彦, 石原一彦, 山岡哲二, 山岡哲二

    人工臓器(日本人工臓器学会)   41 ( 2 )   2012年

     詳細を見る

  • Society for Biomaterials 2011 Annual Meeting & Exposition に参加して

    柿木 佐知朗

    人工臓器   40 ( 3 )   261 - 262   2011年12月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • ステント(3) : ステントの新展開

    柿木 佐知朗, 山岡 哲二

    バイオマテリアル : 生体材料 : journal of Japanese Society for Biomaterials   29 ( 3 )   166 - 173   2011年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本バイオマテリアル学会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2011326319

  • Construction of elastin-like peptide expression vector using BbsI restriction enzyme for neural regeneration

    KAKINOKI Sachiro, YAMAOKA Tetsuji

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2010   279 - 279   2011年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • Modification of PLA Scaffolds Using Bioactive Peptide-Oligo (Lactic Acid) Conjugates

    KAKINOKI Sachiro, UCHIDA Sho, EHASHI Tomo, MURAKAMI Akira, YAMAOKA Tetsuji

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2008   449 - 450   2009年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • Chain-Length Dependence of Conformational Property of Poly(proline)

    YUGE Mitsuhiro, KAKINOKI Sachiro, KITAMURA Makoto, HIRANO Yoshiaki, OKA Masahito

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2006   82 - 83   2007年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • Conformational Transition of Poly(proline) in Various Solvents

    YUGE Mitsuhiro, KAKINOKI Sachiro, HIRANO Yoshiaki, OKA Masahito

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2006   84 - 85   2007年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • Conformation Analysis of Proline-Rich Block Copolypeptides

    YUGE Mitsuhiro, KAKINOKI Sachiro, KAWAGUCHI Takuya, HIRANO Yoshiaki, OKA Masahito

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2006   86 - 87   2007年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • 高親水性高分子を用いた人工血管用スキャホールドの作製と評価

    佐々木愛, 柿木佐知朗, 馬原淳, 中谷武嗣, 山岡哲二

    日本バイオマテリアル学会大会予稿集   29th   2007年

     詳細を見る

  • 体に優しい医療用接着剤

    柿木 佐知朗, 田口 哲志

    ケミカルエンジニヤリング   51 ( 7 )   555 - 560   2006年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:化学工業社  

    CiNii Books

    researchmap

  • Synthesis of novel crosslinkers for promoting spheroid formation

    M Ito, T Taguchi, S Kakinoki, H Kobayashi, J Tanaka

    TISSUE ENGINEERING   12 ( 4 )   1078 - 1078   2006年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MARY ANN LIEBERT INC  

    Web of Science

    researchmap

  • The injectable drug delivery system for anticancer chemotherapy using the novel tissue adhesive: Characterization and in vitro evaluation

    S Kakinoki, T Taguchi, H Kobayashi, J Tanaka

    TISSUE ENGINEERING   12 ( 4 )   1077 - 1077   2006年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:MARY ANN LIEBERT INC  

    Web of Science

    researchmap

  • Solution Property of Random Copolypeptides Composed of Pro and Ala Residues

    KAKINOKI Sachiro, YUGE Mitsuhiro, KITAMURA Makoto, HIRANO Yoshiaki, KAETSU Isao, OKA Masahito

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2005   415 - 418   2006年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • Conformation Analysis of Proline-Rich Block Peptides : I. Synthesis and Experimental Analysis

    KAKINOKI Sachiro, YUGE Mitsuhiro, HIRANO Yoshiaki, OKA Masahito

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2005   407 - 410   2006年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • Conformation Analysis of Proline-Rich Block Peptides : II. Theoretical Analysis

    KAKINOKI Sachiro, YUGE Mitsuhiro, HIRANO Yoshiaki, OKA Masahito

    Peptide science : proceedings of the ... Japanese Peptide Symposium   2005   411 - 414   2006年3月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • SF12-1 孤閨癌に対する温度感作性ゾルーゲル相転移型高分子薬物複合体による新しい癌局所療法の開発

    宮本 正章, 野澤 由香, 井上 一知, 柿木 佐知朗, 嘉 悦勲

    日本外科学会雑誌   102 ( 0 )   108 - 108   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人日本外科学会  

    CiNii Books

    researchmap

  • PP1494 Drug delivery systemを応用した慢性高エンドトキシン血症モデルの開発

    小角 卓也, 臼井 規朗, 窪田 昭男, 内山 勝治, 野上 隆司, 大柳 治正, 廣岡 慎治, 米倉 竹夫, 柿木 佐知朗, 嘉悦 勲

    日本外科学会雑誌   102 ( 0 )   597 - 597   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人日本外科学会  

    CiNii Books

    researchmap

▼全件表示

講演・口頭発表等

  • Single step immobilization of REDV peptide onto a variety of biomaterial substrates by tyrosine oxidation

    Sachiro Kakinoki, Tetsuji Yamaoka

    2014 Annual meeting & exposition of Society for Biomaterials  2014年4月 

     詳細を見る

    開催年月日: 2014年4月

    開催地:Denver, Colorado, USA  

    researchmap

  • Single step peptide immobilization technique onto a variety of biomaterial surfaces by Tyr oxidation and its application for re-endothelialization promoting vascular stent

    Sachiro Kakinoki, Kensuke Takasaki, Yoshiaki Hirano, Tetsuji Yamaoka

    ICBME2013  2013年12月 

     詳細を見る

    開催年月日: 2013年12月

    開催地:Singapore  

    researchmap

  • Biomaterial functionalization by single step peptide immobilization via Tyr oxidation

    Sachiro Kakinoki, Kensuke Takasaki, Yoshiaki Hirano, Tetsuji Yamaoka

    AMWC2013  2013年9月 

     詳細を見る

    開催年月日: 2013年9月

    開催地:Iumir, Turkey  

    researchmap

  • Direct immobilization of cell adhesive peptide onto various substrates using tyrosine oxidation

    Sachiro Kakinoki, Kensuke Takasaki, Yoshiaki Hirano, Tetsuji Yamaoka

    XXXX ESAO  2013年9月 

     詳細を見る

    開催年月日: 2013年9月

    開催地:Glasgow, Scotland  

    researchmap

  • eptide functionalization of intravascular stent surface via oxidation reaction for promoting in situ re-endothelialization

    Sachiro Kakinoki, Kensuke Takasaki, Yoshiaki Hirano, Tetsuji Yamaoka

    20th Meeting of the Korea society for biomaterials  2012年12月 

     詳細を見る

    開催年月日: 2012年12月

    開催地:Seoul, Korea  

    researchmap

  • Non-specific Cellular Responses to the Mobile Surfaces with Polyrotaxane

    Sachiro Kakinoki, Ji-Hun Seo, Kazuhiko Ishihara, Nobuhiko Yui, Tetsuji Yamaoka

    International conference of young researchers on advanced materials  2012年7月 

     詳細を見る

    開催年月日: 2012年7月

    開催地:Singapore  

    researchmap

  • Global Gene Expression Analysis of Biological Responses to the Porous Scaffolds with Different Surfaces

    Sachiro Kakinoki, Yusuke Sakai, Tomo Ehashi, Taro Takemura, Nobutaka Hanagata, Toshia Fujisato, Kazuhiko Ishihara, Nobuhiko Yui, Tetsuji Yamaoka

    9th World Biomaterials Congress  2012年6月 

     詳細を見る

    開催年月日: 2012年6月

    開催地:Chendgu, China  

    researchmap

  • Non-specific and Specific Cellular Responses on the Supramolecular Bio-interface with Mobile Substances

    Sachiro Kakinoki, Ji-Hun Seo, Atsushi Yamashita, Kazuhiko Ishihara, Nobuhiko Yui, Tetsuji Yamaoka

    9th World Biomaterials Congress  2012年6月 

     詳細を見る

    開催年月日: 2012年6月

    開催地:Chendgu, China  

    researchmap

  • Protein adsorption and cell adhesion onto PEG-immobilized surfaces with graft and loop structures

    Takuya Nakagoshi, Sachiro Kakinoki, Yuichi Ohya, Tetsuji Yamaoka

    Softinterface international mini-symposium on biointerface (SIMS2012)  2012年3月 

     詳細を見る

    開催年月日: 2012年3月

    開催地:Tsukuba, Japan  

    researchmap

  • In vivo re-endothelialization of the REDV peptide-immobilized metal surface

    Sachiro Kakinoki, Kensuke Takasaki, Yoshiaki Hirano, Tetsuji Yamaoka

    International Conference on Nanomaterials & nanotechnology (ICNANO2011)  2011年12月 

     詳細を見る

    開催年月日: 2011年12月

    開催地:Delhi, India  

    researchmap

  • Platelet response to PEG-grafted biomaterial surfaces with different chain length and molecular architecture

    Sachiro Kakinoki, Takuya Nakagoshi, Yuuki Inoue, Lin Ye, Yuichi Ohya, Kazuhiko Ishihara, Nobuhiko Yui, Tetsuji Yamaoka

    The 3rd Asian Biomaterials Congress  2011年9月 

     詳細を見る

    開催年月日: 2011年9月

    開催地:Busan, Korea  

    researchmap

  • REDV peptide-immobilized surface for enhanced endotheliarization

    Sachiro Kakinoki, Kensuke Takasaki, Yoshiaki Hirano, Tetsuji Yamaoka

    The 3rd Asian Biomaterials Congress  2011年9月 

     詳細を見る

    開催年月日: 2011年9月

    開催地:Busan, Korea  

    researchmap

  • Thermo-responsive artificial extracellular matrix protein for nerve regeneration

    Sachiro Kakinoki, Tetsuji Yamaoka

    2011 Annual Meeting&Exposition of society for biomaterials  2011年4月 

     詳細を見る

    開催年月日: 2011年4月

    開催地:Orlando, Florida, USA  

    researchmap

  • Platelet response to PEG-modified surface with different molecular architecture

    Sachiro Kakinoki, Lin Ye, Yuuki Inoue, Kazuhiko Ishihara, Nobuhiko Yui, Tetsuji Yamaoka

    2011 Annual Meeting&Exposition of society for biomaterials  2011年4月 

     詳細を見る

    開催年月日: 2011年4月

    開催地:Orlando, Florida, USA  

    researchmap

  • Cell adhesion and tissue regeneration on poly(lactic acid) -based scaffolds modified with oligo(lactic acid) -oligo peptide amphiphilic conjugates

    Sachiro Kakinoki, Tetsuji Yamaoka

    5th International peptide symposium  2010年12月 

     詳細を見る

    開催年月日: 2010年12月

    開催地:Kyoto, Japan  

    researchmap

  • Cell adhesion and tissue regeneration on poly(lactic acid) -based scaffolds modified with oligo(lactic acid) -oligo peptide amphiphilic conjugates

    Sachiro Kakinoki, Tetsuji Yamaoka

    5th International peptide symposium  2010年12月 

     詳細を見る

    開催年月日: 2010年12月

    開催地:Kyoto, Japan  

    researchmap

  • Bioactive interface composed of ECM-like peptides on PLA scaffolds for nerve regeneration

    Sachiro Kakinoki, Tetsuji Yamaoka

    International Symposium on Nanobio-interfaces Related to Molecular Mobility  2009年11月 

     詳細を見る

    開催年月日: 2009年11月

    開催地:Tokyo, Japan  

    researchmap

  • Biosynthesis of thermoresponsive artificial ECM composed of elastin-like repetitive sequence (VPGIG)n and the laminin-derived sequence

    Sachiro Kakinoki, Tetsuji Yamaoka

    8th International Symposium on Frontiers in Biomedical Polymers  2009年5月 

     詳細を見る

    開催年月日: 2009年5月

    開催地:Mishima, Japan  

    researchmap

  • Fundamental Studies of Artificial Extra Cellular Matrix Composed of Laminin-derived sequence

    Sachiro Kakinoki, Kaori Hiraku, Alyssa Panitch, David A. Tirrell, Tetsuji Yamaoka

    The TERMIS North America 2008 Annual Conference & Exposition  2008年12月 

     詳細を見る

    開催年月日: 2008年12月

    開催地:San Diego, USA  

    researchmap

  • Fundamental Studies of Genetically Engineered Elastin Model Peptide for Scaffold Biomaterials

    Sachiro Kakinoki, Wakako Kamata, Alyssa Panitch, David A. Tirrell, Tetsuji Yamaoka

    1st Asia Biomaterial Congress  2007年12月 

     詳細を見る

    開催年月日: 2007年12月

    開催地:Tsukuba, Japan  

    researchmap

  • Experimental Reflection on Conformational Transition of Poly(proline)

    Mitsuhiro Yuge, Sachiro Kakinoki, Yoshiaki Hirano, Masahito Oka

    Fifth East Asian Biophysics Symposium & Forty-Fourth Annual Meeting of the Biophysical Society of Japan  2006年11月 

     詳細を見る

    開催年月日: 2006年11月

    開催地:Okinawa, Japan  

    researchmap

  • Injectable in situ forming drug delivery system with the novel tissue adhesive containing doxorubicin hydrochloride for cancer chemotherapy

    Sachiro Kakinoki, Tetsushi Taguchi, Hisatoshi Kobayashi, Junzo Tanaka

    International Conference on Advances in Biomaterials for Drug Delivery and Regenerative Medicine 2006  2006年6月 

     詳細を見る

    開催年月日: 2006年6月

    開催地:Capri, Italy  

    researchmap

  • Liquid injectable drug delivery system composed of biomacromolecules and organic acid derivatives for cancer chemotherapy

    Sachiro Kakinoki, Tetsushi Taguchi, Hirofumi Saito, Hisatoshi Kobayashi, Junzo Tanaka

    Pacifichem 2005  2005年12月 

     詳細を見る

    開催年月日: 2005年12月

    開催地:Honolulu, USA  

    researchmap

  • The injectable drug delivery system for anticancer chemotherapy using the novel tissue adhesive: Characterization and in vitro evaluation

    Sachiro Kakinoki, Tetsushi Taguchi, Hirofumi Saito, Hisatoshi Kobayashi, Junzo Tanaka

    The 8th Tissue Engineering Society International Annual Meeting  2005年10月 

     詳細を見る

    開催年月日: 2005年10月

    開催地:Shanghai, China  

    researchmap

▼全件表示

産業財産権

  • ポリロタキサンブロック共重合体表面を有する培養器を用いた幹細胞の培養方法

     詳細を見る

    出願番号:特願2015-142025  出願日:2015年7月

    公開番号:特開2017-023008  公開日:2017年2月

    researchmap

  • ペプチド及びその複合体、組織修復用スキャフォールド及びその表面処理方法、並びに表面処理液又は処理液のセット

     詳細を見る

    出願番号:特願2013-094744  出願日:2013年4月

    公開番号:特開2014-214140  公開日:2014年11月

    特許番号/登録番号:特許6202669  登録日:2017年9月 

    researchmap

  • 材料表面修飾方法

    柿木佐知朗

     詳細を見る

    出願番号:特願2012-232061  出願日:2012年10月

    公開番号:特開2014-083104  公開日:2014年5月

    特許番号/登録番号:特許6041132  登録日:2016年11月 

    researchmap

  • 血液凝固抑制材料並びにそれを用いたコーティング材料及び生体留置部材

    山岡 哲二, 加藤 聡, 笠井 厚, 柿木 佐知朗

     詳細を見る

    出願人:国立循環器病センター総長, 三菱化学株式会社

    出願番号:特願2007-298711  出願日:2007年11月

    公開番号:特開2008-142534  公開日:2008年6月

    特許番号/登録番号:特許5297632  登録日:2013年6月 

    J-GLOBAL

    researchmap

  • 複合材料とその製造方法

    田口 哲志, 柿木 佐知朗

     詳細を見る

    出願人:独立行政法人物質・材料研究機構

    出願番号:特願2006-313929  出願日:2006年11月

    公開番号:特開2008-127330  公開日:2008年6月

    J-GLOBAL

    researchmap

  • 局所投与型化学療法用材料

    田口 哲志, 柿木 佐知朗

     詳細を見る

    出願人:独立行政法人物質・材料研究機構

    出願番号:特願2006-160776  出願日:2006年6月

    公開番号:特開2007-325824  公開日:2007年12月

    J-GLOBAL

    researchmap

  • 局所投与型徐放性生体内分解吸収性医用材料

    田口 哲志, 柿木 佐知朗, 田中 順三

     詳細を見る

    出願人:独立行政法人物質・材料研究機構

    出願番号:特願2005-306815  出願日:2005年10月

    公開番号:特開2007-111300  公開日:2007年5月

    J-GLOBAL

    researchmap

  • 固−液混合型二成分系生体内分解吸収性粘着性医用材料

    田口 哲志, 柿木 佐知朗, 田中 順三, 斉藤 浩史

     詳細を見る

    出願人:独立行政法人物質・材料研究機構, フルウチ化学株式会社

    出願番号:特願2005-174414  出願日:2005年6月

    公開番号:特開2006-346049  公開日:2006年12月

    J-GLOBAL

    researchmap

▼全件表示

受賞

  • 日本再生医療学会2013年度YIA優秀賞

    2013年3月   日本再生医療学会  

     詳細を見る

    受賞国:日本国

    researchmap

  • 2012年度日韓バイオマテリアル学会若手研究者交流AWARD

    2012年11月   日本バイオマテリアル学会  

     詳細を見る

    受賞国:日本国

    researchmap

  • 2011年度人工臓器学会Yoshimi memorial T.M.P. Grant賞

    2011年11月   日本人工臓器学会  

     詳細を見る

    受賞国:日本国

    researchmap

共同研究・競争的資金等の研究課題

  • アンチファウリングペプチド固定化技術による体外設置型VADハウジングの血液適合化

    研究課題/領域番号:23KK0204  2023年9月 - 2027年3月

    日本学術振興会  科学研究費助成事業  国際共同研究加速基金(海外連携研究)

    柿木 佐知朗, 岩崎 泰彦, 奥野 陽太, 上田 正人, 高井 真司, 橋本 朋子

      詳細を見る

    配分額:20930000円 ( 直接経費:16100000円 、 間接経費:4830000円 )

    researchmap

  • ペプチド修飾技術を活用した複機能化人工血管の狭窄予防効果の検証

    研究課題/領域番号:22H03929  2022年4月 - 2026年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    柿木 佐知朗

      詳細を見る

    配分額:15470000円 ( 直接経費:11900000円 、 間接経費:3570000円 )

    researchmap

  • ペプチド固定化技術による抗血栓性と内膜再生性を兼備したePTFE人工血管の開発

    研究課題/領域番号:18K12087  2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    柿木 佐知朗, 伊井 正明

      詳細を見る

    配分額:4420000円 ( 直接経費:3400000円 、 間接経費:1020000円 )

    2018年度は、研究計画調書に記載の(1)およびに(2)の一部について検討し、以下の成果を得た。
    (1)ペプチド固定化効率の高いチロシンアンカー配列の設計
    チロシンアンカー配列にリジン残基もしくはグルタミン酸残基を導入したフィブロネクチン由来ペプチド、Ac-(Tyr-Lys)3-Gly3-Leu-Asp-Val (YK3)およびAc-(Tyr-Glu)3-Gly3-Leu-Asp-Val (YE3)を汎用のFmoc固相法で合成し、高純度の両ペプチドを得た。ePTFEフィルムを各ペプチド水溶液に浸漬させ、触媒/酸化剤を添加して50℃で24時間反応後、充分に水洗して試料表面を解析した。その結果、YK3(触媒/酸化剤添加)が他の群と比較して優位に水接触角が減少し、かつXPSでのペプチド由来窒素も強く検出された。さらに、この方法でePTFEフィルム上に固定化されたYK3は、高濃度のSDS水溶液もしくは塩化ナトリウム水溶液で洗浄しても保持されていたことから、チロシン残基とリジン残基間がマイケル付加反応によって架橋構造を形成することで安定な疑似自己組織化層を形成したことが示唆された。
    (2)ペプチド固定化ePTFE基材上への細胞・血小板接着性の評価
    YK3を固定化したePTFEフィルム上にヒト血小板(健康なドナーから提供された全血より多血小板血漿を調製・倫理委員会の承認を得て実施)した。その結果、未修飾とほぼ同様に、YK3を固定化したePTFEフィルム上には血小板は粘着しなかった。血小板はカチオン性表面には粘着する傾向があることを踏まえると、YK3分子中のリジン残基はチロシン残基と反応し、血小板の粘着を引き起こすほどの未反応遊離アミノ基が残存していないことが示唆された。引き続き、YK3固定化ePTFEフィルム上への血管内皮細胞や間葉系幹細胞の接着性を評価し、LDVリガンド固定化効果を検証する。

    researchmap

  • 医用材料に吸着する超微量タンパク質の高感度絶対定量法の開発

    研究課題/領域番号:18K05196  2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    加藤 愛, 柿木 佐知朗

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    本研究では、研究代表者らが過去に構築した同位体希釈質量分析を利用したアミノ酸分析法(IDMS-AAA法)を応用し、医用材料に吸着した超微量タンパク質の絶対量を高感度かつ高精度に定量する方法を開発することを最終目標とする。
    初年度は、まず過去に研究代表者らが確立した現行法(IDMS-AAA法)を改良し、全天然アミノ酸を定量出来る分離・検出が可能で、かつ分析時間を10分程度まで短縮できる条件を検討した。具体的にはAPDS(アミノタグワコー, Rapid Commun. Mass Spectromet., 23(2009)1483)を誘導体化試薬として利用した誘導体化‐LC/MSによるアミノ酸分析法と、HILICカラムを利用した非誘導体化-LC/MSを利用したアミノ酸分析の2種を検討し、後者の方法においては、既存の方法と比較して感度は保ちつつ、分析時間の大幅な短縮(88分/1分析→23分/1分析(洗浄工程・平衡化の時間も含む))と測定対象アミノ酸の拡大(8種→17種)を達成することが出来た。
    次に、モデルタンパク質であるヒト血清アルブミン認証標準物質を約100倍希釈したもの(0.7 mg/mL)について、加水分解条件の検討を行った。結果、加水分解時間については6時間以上で十分であることが分かった。また、17種類中、Cys-Cys,Gly,Thr, Tyrを除く13種類のアミノ酸については定量が可能であることが分かった。
    また、汎用の低タンパク質吸着界面であるポリエチレングリコール固定界面の作製にも着手し、ガラス基材への金の蒸着とチオール-金結合を介したポリエチレングリコールの固定化法を最適化できた。

    researchmap

  • 温度応答性ポリ乳酸ハイドロゲルを利用した心筋梗塞治療システムの開発

    研究課題/領域番号:26670623  2014年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    中谷 武嗣, 山岡 哲二, 柿木 佐知朗, 徐 ユイ

      詳細を見る

    配分額:3640000円 ( 直接経費:2800000円 、 間接経費:840000円 )

    心疾患は我が国の主要死亡原因の一つである。有効な新たな治療法として、比較的脆弱な高分子ゲルを疾患部位に注入することで新機能が改善するとの報告がなされた。本研究では、物性を広範囲に調製できるポリ乳酸-ポリエチレングリコールインジェクタブルゲルの治療効果を検討したところ、従来の非分解性材料と比較して、マイルドな炎症反応で同等の治癒効果を認めた。このことは、分解性をコントロールすることにより従来材料よりも優れた治療デバイスの設計が可能なことを示唆している。

    researchmap

  • 人工材料に対する免疫・炎症反応の網羅的遺伝子発現解析によるin vivo評価

    研究課題/領域番号:25560218  2013年4月 - 2015年3月

    日本学術振興会  科学研究費助成事業 挑戦的萌芽研究  挑戦的萌芽研究

    柿木 佐知朗

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3770000円 ( 直接経費:2900000円 、 間接経費:870000円 )

    人工臓器や歯科用インプラントなどの医療デバイスは、臨床で広く用いられている。これら人工物を生体に埋入すると異物反応が引き起こされるが、その機構は明らかになっていない。本研究では、バイオイナートポリマーとしれ知られるMPC(2-メタクリロイルオキシエチルホスホリルコリン)ポリマーをコートした多孔質ポリエチレンをマウス背部皮下に埋入し、内部に浸潤した細胞の遺伝情報を網羅的に解析することによって、生体反応を詳細に解析した。その結果、MPCポリマーによる初期炎症の強い抑制ならび遅延効果を、炎症関連遺伝子の発現傾向から明らかにした。

    researchmap

  • Development of high-functional biomaterials by using peptide-protein engineering

    2007年

      詳細を見る

    資金種別:競争的資金

    researchmap

  • アミノ酸を用いた金属系生体材料の表面修飾方法の開発

    研究課題/領域番号:19700411  2007年

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    柿木 佐知朗

      詳細を見る

    配分額:1300000円 ( 直接経費:1300000円 )

    researchmap

  • 周期性ポリペプチドの構造解析とその応用に関する研究

    2002年 - 2005年

    科学研究費補助金 

      詳細を見る

    資金種別:競争的資金

    researchmap

  • Study on conformation, molecular propaties and application of repetitive polypeptides

    2002年 - 2005年

    Grant-in-Aid for Scientific Research 

      詳細を見る

    資金種別:競争的資金

    researchmap

▼全件表示